MICA and melanoma: Interestingly, in melanoma cell lines, the downregulation of MICA and ULBP2/5/6 induced by vemurafenib was counterbalanced by the addition of HDACi, potent NKG2D ligand inducers, to the in vitro culture, leading to enhanced NK cell activity [196].